USPTO serial 97551508
SELECT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 12, 2026
- Examiner
- TANNER, MICHAEL R
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SELECT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Susan M. Kornfield
Susan M. Kornfield BODMAN PLC201 S. DIVISION STREETSUITE 400ANN ARBOR, MI 48104Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable reports and documents in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; downloadable reports and documents featuring surgical and medical information in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; downloadable reports and documents featuring surgical information, medical information, and quantitative measures for use in connection with the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions; downloadable reports and documents featuring surgical information, medical information, and quantitative measures for use in connection with the visual readings of lung structures; downloadable reports and documents featuring surgical information, medical information, and quantitative measures for use in confirming the eligibility of patients and the identification of correct target lobes for endobronchial valve treatment; downloadable reports and documents featuring information about medical devices and medical procedures for use in connection with the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions and emphysema disease | ACTIVE | Oct 22, 2020 |
| 016 | Printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing featuring surgical and medical information in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing featuring surgical information, medical information, and quantitative measures for use in connection with the evaluation, surgical treatment, and medical treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions and emphysema disease; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing in the field of pulmonary medicine and quantitative computed tomography analysis; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing in the field of pulmonary medicine featuring surgical information, medical information, and quantitative measures to support visual readings of lung structures; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing in the field of pulmonary medicine featuring surgical information, medical information, and quantitative measures for use in confirming the eligibility of patients and the identification of correct target lobes for endobronchial valve treatment; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing featuring information about medical devices and medical procedures for use in connection with the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions and emphysema disease | ACTIVE | Oct 22, 2020 |
| 042 | Providing temporary use of online non-downloadable software for quantitative computed tomography analysis in the field of pulmonary medicine and pulmonary disease, and generating reports corresponding to the foregoing; providing temporary use of online non-downloadable software featuring artificial intelligence for quantitative computed tomography analysis in the field of pulmonary medicine and pulmonary disease, and generating reports corresponding to the foregoing; providing temporary use of on-line non-downloadable software for analyzing patient data in the field of pulmonary medicine and the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions, and emphysema disease and generating reports corresponding to the foregoing; software as a service (SAAS) services featuring software for analyzing patient data in the field of pulmonary medicine and the evaluation and treatment of chronic obstructive pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions, and emphysema disease, and generating reports corresponding to the foregoing; software as a services (SAAS) services featuring software for quantitative data analysis of computed tomography scans and generating corresponding reports, all in the field of pulmonary medicine; software as a services (SAAS) services featuring software using artificial intelligence for quantitative data analysis of computed tomography scans and generating corresponding reports, all in the field of pulmonary medicine; software as a services (SAAS) services featuring temporary use of non-downloadable software for use in securely accessing and submitting medical information in the form of computed tomography scans, receiving quantitative data analysis of computed tomography scans, and generating corresponding reports, all in the field of pulmonary medicine; software as a services (SAAS) services featuring temporary use of non-downloadable software for use in securely accessing surgical information, medical information, and quantitative measures to support visual readings of lung structures, all in the field of pulmonary medicine; software as a services (SAAS) services featuring temporary use of non-downloadable software for use in securely accessing surgical information, medical information, and quantitative measures for use in confirming the eligibility of patients and the identification of correct target lobes for endobronchial valve treatment; software as a services (SAAS) services featuring temporary use of non-downloadable software for use in securely accessing information about medical devices and medical procedures for use in connection with the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions, and emphysema disease | ACTIVE | Oct 22, 2020 |
| 044 | Providing medical information regarding medical devices for the treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions, and emphysema disease; medical diagnostic testing, monitoring and reporting services in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; medical information services, namely, analysis and reporting services relating to the treatment of patients based on quantitative measurements of computed tomography scans in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; providing online medical record analysis services designed to provide patients and practitioners with customized data used to inform and recommend treatment options in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; providing a website featuring online medical information regarding medical devices and medical procedures for use in connection with the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions, and emphysema disease | ACTIVE | Oct 22, 2020 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Olympus Corporation
- Other trademarks owned by Olympus Corporation
- Other trademarks owned by Olympus Corporation
- Other trademarks in Class 009
- Other trademarks in Class 016
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named SELECT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 12, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 12, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 17, 2026 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Apr 17, 2026 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Mar 30, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Mar 30, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 30, 2025 | IUAF | USE AMENDMENT FILED | — |
| Sep 30, 2025 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Apr 2, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 1, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Apr 1, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Apr 1, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 17, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 17, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Sep 17, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 17, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 2, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 6, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 6, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 17, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 31, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 21, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 21, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 21, 2023 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Dec 11, 2023 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jun 13, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jun 13, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jun 13, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 13, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 13, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 13, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 13, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 2, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 7, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 19, 2022 | NWAP | NEW APPLICATION ENTERED | — |